SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001104659-17-050286
Filing Date
2017-08-08
Accepted
2017-08-08 16:39:23
Documents
67
Period of Report
2017-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q a17-13369_110q.htm 10-Q 1207914
2 EX-3.2 a17-13369_1ex3d2.htm EX-3.2 10896
3 EX-31.1 a17-13369_1ex31d1.htm EX-31.1 10454
4 EX-31.2 a17-13369_1ex31d2.htm EX-31.2 11256
5 EX-32.1 a17-13369_1ex32d1.htm EX-32.1 4269
6 EX-32.2 a17-13369_1ex32d2.htm EX-32.2 4278
  Complete submission text file 0001104659-17-050286.txt   5748794

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE DOCUMENT stml-20170630.xml EX-101.INS 1406141
8 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT stml-20170630.xsd EX-101.SCH 43254
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT stml-20170630_cal.xml EX-101.CAL 46666
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT stml-20170630_def.xml EX-101.DEF 135813
11 XBRL TAXONOMY EXTENSION LABELS LINKBASE DOCUMENT stml-20170630_lab.xml EX-101.LAB 409702
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT stml-20170630_pre.xml EX-101.PRE 275199
Mailing Address 750 LEXINGTON AVENUE NEW YORK NY 10022
Business Address 750 LEXINGTON AVENUE ELEVENTH FLOOR NEW YORK NY 10022 646-502-2311
STEMLINE THERAPEUTICS INC (Filer) CIK: 0001264587 (see all company filings)

IRS No.: 450522567 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35619 | Film No.: 171015346
SIC: 2834 Pharmaceutical Preparations